Pfizer C.E.O. Albert Bourla Wins Jewish Nobel Prize (Genesis Prize)

January 19, 2022, Jerusalem – "Today, The Genesis Prize Foundation announced Dr. Albert Bourla, Chairman and CEO of Pfizer, as the 2022 Genesis Prize Laureate. Dr. Bourla received the largest number of votes in a recently concluded global campaign, during which 200,000 people in 71 countries voted online. The choice of the voters was unanimously endorsed by the nine judges on the Genesis Prize Selection Committee."

"The Committee commended Dr. Bourla for his leadership, determination, and especially for his willingness to assume great risks. Unlike CEOs of most other major companies working on developing COVID-19 vaccines, Dr. Bourla declined billions of dollars in US federal subsidies in order to avoid government bureaucracy and expedite development and production of the vaccine. As a result, Pfizer’s COVID-19 vaccine was ready in record time: months instead of years."

"The Committee also noted Dr. Bourla’s pride in his Jewish identity and heritage, commitment to Jewish values and support for the State of Israel."

"The annual $1 million Genesis Prize, dubbed the “Jewish Nobel” by TIME Magazine, honors extraordinary individuals for their outstanding professional achievement, contribution to humanity, and commitment to Jewish values. Dr. Bourla becomes the ninth Genesis Prize Laureate. He follows filmmaker and philanthropist Steven Spielberg, who was awarded the Genesis Prize in 2021, and the legendary human rights activist Natan Sharansky, the 2020 Laureate."

"The President of Israel Isaac Herzog will present the Genesis Prize to Dr. Bourla at a ceremony in Jerusalem planned for June 29."

articles: https://www.genesisprize.org/press-center/2022-01-19-jewish-nobel-awarded-to-pfizer-ceo-albert-bourla

https://finance.yahoo.com/news/jewish-nobel-awarded-pfizer-ceo-221300561.html